Pharmaceutical Stocks
Pharmaceutical Stocks
A full list of publicly traded pharmaceutical companies, pharmaceutical ETFS and recent pharmaceutical IPOs can be found by scrolling down or you can access a list of the companies in each group by the industry links on this page.
To help our visitors navigate this group of companies we have organized our pharmaceutical section into two primary categories: market capitalization and specific areas of focus.
Large, Mid, Small and Micro-Cap Pharmaceuticals: Each of these sections is comprised of stocks based on market capitalization:
Large-Cap Pharmaceuticals: These stocks have a market capitalization over ten billion dollars.
Mid-Cap Pharmaceuticals: These stocks have a market capitalization between two and ten billion dollars.
Small-Cap Pharmaceuticals: These stocks have a market capitalization between 300 million and two billion dollars.
Micro-Cap Pharmaceuticals: These stocks have a market capitalization less than 300 million dollars.
We update these pages at the start of every month so it is possible that during the course of a month a stock’s market cap might fall below or go above these capitalization levels.
Healthcare Focus Areas: In these sections you will find medical device, biotech, pharmaceutical or other healthcare companies that provide drugs, equipment, products, services or therapeutics in a number of different categories including:
Specific/Classes of Diseases: Cancer, Diabetes, Infectious Diseases, Multiple Sclerosis, Neurological, and Rare Diseases.
Areas of the Body: Blood, Central Nervous System, Dental, Ears, ENT, Eye Care, Gastrointestinal, Heart, Kidney, Liver, Respiratory Health, Skin Care, Spine, Urology and Vascular.
Specific Demographics: Animal Health, Children and Women’s Health.
You will also find a number of other specialty categories including:
Related Links:
List of Companies in the Healthcare Sector
Industry Links: Pharmaceutical Stocks
Select the link to access a full list of companies in the selected category along with industry profiles, charts, comparative widgets and links to individual companies.
Large-Cap Pharmaceutical Companies
Mid-Cap Pharmaceutical Companies
Healthcare Areas of Focus
Healthcare Areas of Focus
Pharmaceutical Industry Resources
Pharmaceutical ETFs
There are a handful of ETFs focusing on publicly traded pharmaceutical companies listed on U.S. exchanges, all of which come from well-known ETF providers. These ETFs are generally comprised of between 25 and 40 pharmaceutical companies and historically have been weighted towards familiar large-cap companies.
SPDR S&P Pharmaceuticals ETF (XPH)
Market Vectors Pharmaceutical ETF (PPH)
PowerShares Dynamic Pharmaceuticals Portfolio (PJP)
iShares U.S. Pharmaceuticals ETF (IHE)
Pharmaceutical Comparative Widgets
Large-Cap Pharmaceutical Industry Comparison Widget
Mid-Cap Pharmaceutical Industry Comparison Widget
Small-Cap Pharmaceutical Industry Comparison Widget
Micro-Cap Pharmaceutical Industry Comparison Widget
Pharmaceutical and Biotech IPOs in 2016
AC Immune SA (ACIU) (IPO September 23: biopharmaceutical company focused on diseases that are associated with protein misfolding)
Aeglea BioTherapeutics, Inc. (AGLE) (IPO April 7, 2016: Biotech company focused on therapeutics for the treatment of inborn errors of metabolism (IEM) and cancer)
Audentes Therapeutics, Inc. (BOLD) (IPO July 20, 2016: biotech company focused on therapy treatments for rare diseases)
Avexis Inc. (AVXS) (IPO February 11, 2016: Gene therapy company with a focus on rare neurological genetic diseases)
AzurRx BioPharma, Inc. (AZRX) (IPO October 11, 2016: Development stage biopharmaceutical company focused on gastrointestinal disorders)
Beigene, Ltd. (BGNE) (IPO February 3, 2016: Biopharmaceutical company with therapeutics designed to treat cancer)
Cellect Biotechnology Ltd. (APOP) (IPO July 29, 2016: biotech company with functional stem cells selection platform)
Clearside Biomedical, Inc. (CLSD) (IPO June 2, 2016: biopharmaceutical company focused on therapies for blinding eye diseases)
Corvus Pharmaceuticals, Inc. (CRVS) (IPO March 23, 2016: Biopharmaceutical company focused on immuno-oncology therapies for cancer)
Editas Medicine, Inc. (EDIT) (IPO February 3, 2016: Genome editing company)
Gemphire Therapeutics Inc. (GEMP) (IPO August 5, 2016: biopharmaceutical company focused on therapies to treat dyslipidemia)
Hutchison China MediTech Limited (HCM) (IPO March 17, 2016: Biopharmaceutical company focused on immunological diseases and oncology in addition to consumer health products)
Intellia Therapeutics, Inc. (NTLA) (IPO May 6, 2016: gene editing company)
Kadmon Holdings, Inc. (KDMN) (IPO July 27, 2016: biopharmaceutical company developing product candidates within autoimmune and fibrotic diseases, oncology and genetic diseases)
Merus N.V. (MRUS) (IPO May 19, 2016, Netherlands: immuno-oncology company)
Moleculin Biotech, Inc. (MBRX) (Clinical stage pharmaceutical company, anticancer drug candidates)
Myovant Sciences Ltd. (MYOV) (IPO October 27, 2016: biopharmaceutical company, women’s health and other endocrine-related disorders)
Novan, Inc. (NOVN) (IPO September 21, 2016: late stage pharmaceutical company; dermatology therapies)
Oncobiologics, Inc. (ONS) (IPO May 13, 2016: biopharmaceutical company focused on biosimilar therapeutics)
Phaserx, Inc. (PZRX) (IPO May, 18 2016: biopharmaceutical company focused on treatments for enzyme deficiencies in the liver)
Proteostasis Therapeutics, Inc. (PTI) (IPO February 11, 2016: Biopharmaceutical company with an initial focus on cystic fibrosis)
Protagonist Therapeutics, Inc. (PTGX) (IPO August 11, 2016: biopharmaceutical company with a platform focused on discovering and developing peptide-based new chemical entities)
Ra Pharmaceuticals, Inc. (RARX) (IPO October 26, 2016: biopharmaceutical company, therapeutics for complement-mediated diseases)
Reata Pharmaceuticals, Inc. (RETA) (IPO May 26, 2016: biopharmaceutical company focused on developing drugs that modulate the activity of important regulatory proteins)
Selecta Biosciences, Inc. (SELB) (IPO June 22, 2016: clinical-stage biopharmaceutical company focused on products designed to modulate the immune system)
Spring Bank Pharmaceuticals, Inc. (SBPH) (IPO May 6, 2016: biopharmaceutical company focused on viral diseases)
Syndax Pharmaceuticals, Inc. (SNDX) (IPO March 3, 2016: Biopharmaceutical company engaged in the development of cancer treatments)
Syros Pharmaceuticals, Inc. (SYRS) (IPO June 30, 2016: Biopharmaceutical company, gene control medicines)
List of Publicly Traded Pharmaceutical Stocks
Abbott Laboratories (ABT) (Nutritional products; medical devices, diagnostics, pharmaceuticals: generic pharmaceuticals gastroenterology products, therapeutic nutrition for dialysis patients, women’s health products, cardiovascular and metabolic, pain and nervous system, respiratory drugs, vaccines; vascular products)
AcelRx Pharmaceuticals, Inc. (ACRX) (Therapies for the treatment of acute pain)
Aclaris Therapeutics, Inc. (ACRS) (IPO in October 2015: Specialty pharmaceutical company: dermatologic treatments)
Adamas Pharmaceuticals, Inc. (ADMS) (Chronic disorders of the central nervous system)
Adamis Pharmaceuticals Corporation (ADMP) (Respiratory disease, allergy)
Aerie Pharmaceuticals, Inc. (AERI) (Therapies for the treatment of patients with glaucoma)
Agile Therapeutics, Inc. (AGRX) (Contraceptive products)
Akorn, Inc. (AKRX) (Generic prescription, branded prescription, animal health, consumer health products)
Alimera Sciences, Inc. (ALIM) (Ophthalmic pharmaceuticals)
Allergan plc (AGN) (Generics, biosimilars, dermatology and aesthetics, central nervous system, eye care, women’s health and urology, GI and cystic fibrosis, cardiovascular and infectious disease)
AMAG Pharmaceuticals, Inc. (AMAG) (Chronic kidney disease, oral rinse for oral mucositis, umbilical cord blood stem cell collection and storage)
AmerisourceBergen Corporation (ABC) (Pharmaceutical sourcing and distribution)
Amphastar Pharmaceuticals, Inc. (AMPH) (Generic and branded injectable and inhalation products)
Antares Pharma, Inc. (ATRS) (Self-injection pharmaceutical products; topical gel-based products)
Aquinox Pharmaceuticals, Inc. (AQXP) (Canada: Drug candidates to treat inflammation and cancer)
Aradigm Corporation (ARDM) (Severe respiratory disease)
Aralez Pharmaceuticals Inc. (ARLZ) (Specialty pharmaceutical company: cardiovascular, pain management)
Aratana Therapeutics, Inc. (PETX) (Pet therapeutics company)
Avadel Pharmaceuticals plc (AVDL) (Drug delivery, anesthesia related products)
Avenue Therapeutics, Inc. (ATXI) (IPO June 27, 2017; specialty pharmaceutical company: postoperative pain management)
BioDelivery Sciences International, Inc. (BDSI) (Pain management and addiction medicine)
BioPharmX Corporation (BPMX) (Specialty pharmaceuticals: women’s health and dermatology)
Biostar Pharmaceuticals, Inc. (BSPM) (China: manufacturer of pharmaceutical and health supplement products; over-the-counter medicine for chronic hepatitis B)
Cambrex Corporation (CBM) (Products and services designed to accelerate and improve the development and commercialization of new and generic therapeutics)
Cardinal Health, Inc. (CAH) (Drug and healthcare product distribution, consumer healthcare products, direct-to-home medical supplies distributor)
Cardiome Pharma Corporation (CRME) (Canada: heart disease)
Catalent, Inc. (CTLT) (Delivery technologies and development solutions for drugs, biologics and consumer health products)
Collegium Pharmaceutical, Inc. (COLL) (IPO in May 2015: Products designed to treat chronic pain while deterring drug abuse/misuse)
Corcept Therapeutics Incorporated (CORT) (Disorders associated with the steroid hormone cortisol)
Corium International, Inc. (CORI) (Transdermal and transmucosal delivery systems; Alzheimer’s disease; partners include Procter & Gamble)
Cumberland Pharmaceuticals Inc. (CPIX) (Acetaminophen poisoning; pain and fever; prescription laxative; hyponatremia; H. pylori and duodenal ulcer disease; kidney failure)
Depomed, Inc. (DEPO) (Pain and other central nervous system conditions)
Dova Pharmaceuticals, Inc. (DOVA) (IPO June 29, 2017; pharmaceutical company: thrombocytopenia)
Dr. Reddy’s Laboratories Ltd. (RDY) (India, generics: anti-infective, cardiovascular disease, dermatology, gastrointestinal ailments, oncology, pain management, pediatrics)
Eagle Pharmaceuticals, Inc. (EGRX) (Injectable products: critical care and oncology)
Egalet Corporation (EGLT) (Medicines for patients with moderate to severe pain)
Eli Lilly and Company (LLY) (Animal health, cardiovascular, critical care, diabetes, men’s health, musculoskeletal, neuroscience, oncology)
Endo International Plc. (ENDP) (Ireland: branded pharmaceutical and generic pharmaceutical products; allergy immunotherapy, central precocious puberty, dermatology, infectious disease, insomnia, orthopedics, pain, pelvic health, urology, men’s and women’s health)
Esperion Therapeutics, Inc. (ESPR) (LDL-C lowering therapies)
ESSA Pharma Inc. (EPIX) (Canada: small molecule drugs for the treatment of prostate cancer)
Evoke Pharma, Inc. (EVOK) (Drugs to treat gastrointestinal disorders and diseases)
Eyegate Pharmaceuticals, Inc. (EYEG) (Specialty pharmaceutical and drug delivery company: therapies and drug delivery technologies)
Flexion Therapeutics, Inc. (FLXN) (Pain therapies for the sufferers of musculoskeletal diseases)
Foamix Pharmaceuticals Ltd. (FOMX) (Israel: treatment of moderate-to-severe acne and impetigo)
GlaxoSmithKline Plc. (GSK) (United Kingdom: prescription medicines, vaccines and consumer healthcare products)
GW Pharmaceuticals Plc (GWPH) (United Kingdom: Cannabinoid prescription medicines: Sativex® (multiple sclerosis); Epidiolex® (childhood epilepsy))
Heron Therapeutics, Inc. (HRTX) (Pharmaceutical products for patients suffering from cancer or pain)
Immune Pharmaceuticals Inc. (IMNP) (Antibody therapeutics: inflammatory diseases and cancer)
Impax Laboratories, Inc. (IPXL) (Generics; branded business focusing on Central Nervous System products)
Insys Therapeutics, Inc. (INSY) (Supportive care products: spray drug delivery technology)
Intellipharmaceutics International Inc. (IPCI) (Canada: controlled-release and targeted-release oral solid dosage drugs)
Ironwood Pharmaceuticals, Inc. (IRWD) (Gastrointestinal disorders)
Johnson & Johnson (JNJ) (Consumer health products: baby care, skin care, oral care, wound care and women’s health care; Medical devices: diabetes care, diagnostics, orthopaedics, neurological disease, vision care, infection prevention, cardiovascular disease and aesthetics; Pharmaceutical: cardiovascular and metabolic diseases, immunology, infectious diseases, neuroscience, oncology)
Juniper Pharmaceuticals, Inc. (JNP) (Women’s health)
Karyopharm Therapeutics Inc. (KPTI) (Drugs for the treatment of cancer and other major diseases)
KemPharm Inc. (KMPH) (IPO in April 2015: Specialty pharmaceutical company: prodrugs that are designed to improve one or more attributes of currently approved drugs; pipeline includes pain, ADHD and CNS indications)
Lannett Co Inc. (LCI) (Generic pharmaceuticals)
Lipocine Inc. (LPCN) (Testosterone replacement)
McKesson Corporation (MCK) (Pharmaceutical distributor; software; automation technology; business services and consulting; Health Mart retail pharmacy franchises)
Melinta Therapeutics, Inc. (MLNT) (Antibacterial products used in the treatment of infectious diseases)
Merck & Company, Inc. (MRK) (Pharmaceuticals: cardiovascular, diabetes, general medicine, immunology, infectious diseases, oncology, respiratory, women’s health; Vaccines, Animal Health Products)
Midatech Pharma plc (MTP) (Oncology treatment and supportive care products)
Moleculin Biotech, Inc. (MBRX) (IPO June 2, 2016: clinical stage pharmaceutical company, anticancer drug candidates)
Mylan Inc. (MYL) (Generic, branded generic and specialty pharmaceuticals)
Neos Therapeutics, Inc. (NEOS) (IPO in July 2015: Attention deficit hyperactivity disorder)
Novan, Inc. (NOVN) (IPO September 21, 2016: late stage pharmaceutical company; dermatology therapies)
Novartis AG (NVS) (Switzerland: eye care, generic pharmaceuticals, medicines, over-the-counter products, vaccines)
Novo Nordisk (NVO) (Denmark: diabetes and other serious chronic conditions)
Novus Therapeutics, Inc. (NVUS) (Specialty pharmaceutical company: ear, nose and throat disorders)
Oasmia Pharmaceutical AB (OASM) (IPO in October 2015, Sweden: Human and animal oncology)
Oculus Innovative Sciences, Inc. (OCLS) (Specialty pharmaceuticals: dermatological conditions and advanced tissue care)
Odonate Therapeutics, Inc. (ODT) (IPO December 7, 2017; pharmaceutical company: cancer)
Opko Health Inc. (OPK) (Point-of-care diagnostics; molecular diagnostics, pharmaceuticals, vaccines)
OptiNose, Inc. (OPTN) (IPO October 13, 2017; specialty pharmaceutical company: ear, nose and throat products)
Oramed Pharmaceuticals Inc. (ORMP) (Israel: platform for oral delivery of drugs)
Pacira Pharmaceuticals, Inc. (PCRX) (Pharmaceutical products for use in hospitals and ambulatory surgery centers)
Phibro Animal Health Corporation (PAHC) (Animal health and mineral nutrition company focused on animals for food production)
Pernix Therapeutics Holdings, Inc. (PTX) (Specialty, primary care and generic medicines; neurology and pain management)
Perrigo Company (PRGO) (Ireland: generic over-the-counter, prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients)
Pfizer, Inc. (PFE) (Consumer healthcare products; vaccines; oncology; examples of medicines include treatments for the following areas: cardiovascular/metabolic, inflammation, neuroscience, pain, rare diseases, women’s/men’s health)
PLx Pharma Inc. (PLXP) (Develops safer/more effective aspirin products using its PLxGuard delivery system)
Prestige Brand Holdings, Inc. (PBH) (Brands include Chloraseptic, Clear Eyes, Compound W, Efferdent, Monistat, Luden’s, Nix and PediaCare)
ProPhase Labs, Inc. (PRPH) (Over-the-counter cold remedy, consumer health products, natural base health products, supplements, cosmeceuticals)
Recro Pharma, Inc. (REPH) (Non-opioid therapeutics for the treatment of acute post-operative pain)
Repligen Corporation (RGEN) (Consumable products used in the process of manufacturing biological drugs)
Ritter Pharmaceuticals Inc. (RTTR) (IPO in June 2015: Specialty pharmaceutical company: gastrointestinal diseases)
Sanofi (SNY) (France: animal health products, consumer healthcare products, generic drugs, vaccines; drugs for diabetes, rare diseases, multiple sclerosis and oncology)
Savara Inc. (SVRA) (Specialty pharmaceutical company: rare respiratory diseases)
scPharmaceuticals Inc. (SCPH) (IPO November 17, 2017; pharmaceutical company: products designed to be delivered via subcutaneous (under the skin) administration)
SCYNEXIS, Inc. (SCYX) (Serious and life-threatening invasive fungal infections)
Sol-Gel Technologies Ltd. (SLGL) (IPO February 1, 2018; Israel: pharmaceutical company: dermatology)
SteadyMed Ltd (STDY) (IPO in March 2015: Specialty pharmaceutical company; pump delivery products for injectable drugs)
Supernus Pharmaceuticals, Inc. (SUPN) (Central nervous system diseases, epilepsy)
Taro Pharmaceutical Industries Ltd. (TARO) (Israel: generic and branded prescription; over-the-counter pharmaceutical products)
Teligent, Inc. (TLGT) (Generics: topical and injectable prescription medicines)
Tetraphase Pharmaceuticals, Inc. (TTPH) (Antibiotics platform based on the tetracycline core)
Teva Pharmaceutical Industries Limited (TEVA) (Israel: generic drugs, specialty pharmaceuticals, active pharmaceutical ingredients)
The Medicines Company (MDCO) (Acute cardiovascular, surgery and perioperative, infectious diseases)
TherapeuticsMD, Inc. (TXMD) (Products specifically for women: prescription, generic prescription, and over-the-counter products)
Valeant Pharmaceuticals International, Inc. (VRX) (Canada: specialty pharmaceuticals, branded generics and consumer products)
VTV Therapeutics Inc. (VTVT) (IPO in July 2015: Clinical stage pharmaceutical company: cancer, central nervous system disorders, diabetes and metabolic disorders, inflammation)
Zoetis Inc. (ZTS) (Animal health medicines and vaccines, diagnostic products and genetic tests)
Zogenix, Inc. (ZGNX) (Therapies for CNS and pain-related conditions)
Zosano Pharma Corporation (ZSAN) (IPO in January 2015: Drug delivery: osteoporosis, hypoglycemia and migraine)